To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Daphne Zohar is founder and managing partner of PureTech ...

Daphne Zohar is the founder and CEO of Seaport Therapeutics. From the Boston Business Journal: Daphne Zohar’s Seaport Therapeutics is joining the growing list of Boston biotechs looking to debut on ...

The team behind Karuna Therapeutics, the Boston biotech that was bought by drug giant Bristol Myers Squibb in a $14 billion deal in December, launched another company on Tuesday called Seaport ...

Bharatt Chowrira, Ph.D., J.D., named Chief Executive Officer of PureTech; PureTech Co-founder, Eric Elenko, Ph.D., promoted to President PureTech Founding Chief ...

Listen to the full episode of this week’s Readout LOUD here. Biotech analyst Brian Skorney and longtime biotech executive Daphne Zohar joined this week’s episode of “The Readout LOUD” to discuss how a ...

Daphne Zohar, the founder of PureTech Ventures, isn’t afraid to take big technical risks when it comes to funding new innovations. Nor is she necessarily put off by technologies that demonstrate ...

Seaport Therapeutics said today it has closed on an oversubscribed $225 million Series B financing, with the proceeds set to be used toward enhancing its Glyph™ technology platform, which has shown ...

Daphne Zohar is the driving force behind an interesting and potentially unique biotech company based in the Boston Seaport district called PureTech Health. The company’s founder and CEO was our ...

Biotech analyst Brian Skorney and longtime biotech executive Daphne Zohar joined this week’s episode of “The Readout LOUD” to discuss how a new Trump administration may affect the Food and Drug ...